Using mice specifically lacking CD40-TRAF6 or CD40-TRAF2/3/5 interactions, we showed that only CD40-TRAF6-deficient mice had a skewing in the immune response toward an anti-inflammatory profile and were protected against atherosclerosis (107). Here, TRAF6 is linked to atherosclerosis.